Bluetongue virus without NS3/NS3a expression is not virulent and protects against virulent bluetongue virus challenge

Journal of General Virology

Volumn 95, Issue PART 9, 2014, Pages 2019-2029

  Feenstra, Femke ^a,b   van Gennip, René G P ^a   Maris Veldhuis, Mieke ^a   Verheij, Eline ^a   van Rijn, Piet A ^a,c  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c NORTH WEST UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BLUETONGUE VIRUS 1 VACCINE; BLUETONGUE VIRUS 6 VACCINE; BLUETONGUE VIRUS 8 VACCINE; NEUTRALIZING ANTIBODY; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 3A; PROTEIN VP2; PROTEIN VP7; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIVIRAL THERAPY; ARTICLE; BLUETONGUE; BLUETONGUE ORBIVIRUS; BLUETONGUE VIRUS 1; BLUETONGUE VIRUS 6; BLUETONGUE VIRUS 8; CONTROLLED STUDY; EXPERIMENTAL SHEEP; FEMALE; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROCONVERSION; SEROTYPE; VACCINATION; VIREMIA; VIRUS MUTANT; VIRUS TITRATION; VIRUS VIRULENCE;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BLUETONGUE; BLUETONGUE VIRUS; CAPSID PROTEINS; CELL LINE; CRICETINAE; FEMALE; GENE KNOCKOUT TECHNIQUES; SHEEP; VACCINATION; VIRAL CORE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS; VIRAL VACCINES; VIREMIA;

EID: 84906245490     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.065615-0     Document Type: Article

References (57)

1. Anderson, J., Mertens, P. P. C. & Herniman, K. A. J. (1993). A competitive ELISA for the detection of anti-tubule antibodies using a monoclonal antibody against bluetongue virus non-structural protein NS1. J Virol Methods 43, 167-175.
2. Anderson, J., Hagglund, S., Breard, E., Comtet, L., Lovgren Bengtsson, K., Pringle, J., Zientara, S. & Valarcher, J. F. (2013). Evaluation of the immunogenicity of an experimental subunit vaccine that allows differentiation between infected and vaccinated animals against Bluetongue virus serotype 8 in cattle. Clin Vaccine Immunol 20, 1115-1122.
3. Bahnemann, H. G. (1990). Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethylenimine. Vaccine 8, 299-303.
4. Barros, S. C., Cruz, B., Luís, T. M., Ramos, F., Fagulha, T., Duarte, M., Henriques, M. & Fevereiro, M. (2009). A DIVA system based on the detection of antibodies to non-structural protein 3 (NS3) of bluetongue virus. Vet Microbiol 137, 252-259.
5. Batten, C. A., Maan, S., Shaw, A. E., Maan, N. S. & Mertens, P. P. (2008). A European field strain of bluetongue virus derived from two parental vaccine strains by genome segment reassortment. Virus Res 137, 56-63.
6. Belhouchet, M., Mohd Jaafar, F., Firth, A. E., Grimes, J. M., Mertens, P. P. & Attoui, H. (2011). Detection of a fourth orbivirus nonstructural protein. PLoS ONE 6, e25697.
7. Bhanuprakash, V., Indrani, B. K., Hosamani, M., Balamurugan, V. & Singh, R. K. (2009). Bluetongue vaccines: the past, present and future. Expert Rev Vaccines 8, 191-204.
8. Boone, J. D., Balasuriya, U. B., Karaca, K., Audonnet, J. C., Yao, J., He, L., Nordgren, R., Monaco, F., Savini, G. & other authors (2007). Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep. Vaccine 25, 672-678.
9. Bougrine, S. I., Fihri, O. F. & Fehri, M. M. (1998). Western immunoblotting as a method for the detection of African horse sickness virus protein-specific antibodies: differentiation between infected and vaccinated horses. Arch Virol Suppl 14, 329-336.
10. Boyce, M., Celma, C. C. & Roy, P. (2008). Development of reverse genetics systems for bluetongue virus: recovery of infectious virus from synthetic RNA transcripts. J Virol 82, 8339-8348.
11. Calvo-Pinilla, E., Castillo-Olivares, J., Jabbar, T., Ortego, J., de la Poza, F. & Marin-Lopez, A. (2014). Recombinant vaccines against bluetongue virus. Virus Res 182, 78-86.
12. Celma, C. C. & Roy, P. (2009). A viral nonstructural protein regulates bluetongue virus trafficking and release. J Virol 83, 6806-6816.
13. Celma, C. C. & Roy, P. (2011). Interaction of calpactin light chain (S100A10/p11) and a viral NS protein is essential for intracellular trafficking of nonenveloped bluetongue virus. J Virol 85, 4783-4791.
14. Celma, C. C., Boyce, M., van Rijn, P. A., Eschbaumer, M., Wernike, K., Hoffmann, B., Beer, M., Haegeman, A., De Clercq, K. & Roy, P. (2013). Rapid generation of replication-deficient monovalent and multivalent vaccines for bluetongue virus: protection against virulent virus challenge in cattle and sheep. J Virol 87, 9856-9864.
15. Chauveau, E., Doceul, V., Lara, E., Breard, E., Sailleau, C., Vidalain, P.-O., Meurs, E. F., Dabo, S., Schwartz-Cornil, I. & other authors (2013). NS3 of bluetongue virus interferes with the induction of type I interferon. J Virol 87, 8241-8246.
16. Coetzee, P., Stokstad, M., Venter, E. H., Myrmel, M. & Van Vuuren, M. (2012). Bluetongue: a historical and epidemiological perspective with the emphasis on South Africa. Virol J 9, 198.
17. Di Gialleonardo, L., Migliaccio, P., Teodori, L. & Savini, G. (2011). The length of BTV-8 viraemia in cattle according to infection doses and diagnostic techniques. Res Vet Sci 91, 316-320.
18. Eschbaumer, M., Hoffmann, B., Moss, A., Savini, G., Leone, A., König, P., Zemke, J., Conraths, F. & Beer, M. (2010). Emergence of bluetongue virus serotype 6 in Europe-German field data and experimental infection of cattle. Vet Microbiol 143, 189-195.
19. Feenstra, F., van Gennip, R. G. P., van de Water, S. G. P. & van Rijn, P. A. (2014). RNA elements in open reading frames of the bluetongue virus genome are essential for virus replication. PLoS ONE 9, e92377.
20. Ferrari, G., De Liberato, C., Scavia, G., Lorenzetti, R., Zini, M., Farina, F., Magliano, A., Cardeti, G., Scholl, F. & other authors (2005). Active circulation of bluetongue vaccine virus serotype-2 among unvaccinated cattle in central Italy. Prev Vet Med 68, 103-113.
21. Haig, D. A., McKercher, D. G. & Alexander, R. A. (1956). The cytopathic action of bluetongue virus in tissue culture and its application to the detection of antibodies in the serum of sheep. Onderstepoort J Vet Res 27, 171-177.
22. Hofmann, M. A., Renzullo, S., Mader, M., Chaignat, V., Worwa, G. & Thuer, B. (2008). Genetic characterization of toggenburg orbivirus, a new bluetongue virus, from goats, Switzerland. Emerg Infect Dis 14, 1855-1861.
23. Huismans, H., van der Walt, N. T., Cloete, M. & Erasmus, B. J. (1987). Isolation of a capsid protein of bluetongue virus that induces a protective immune response in sheep. Virology 157, 172-179.
24. Huismans, H., van Staden, V., Fick, W. C., van Niekerk, M. & Meiring, T. L. (2004). A comparison of different orbivirus proteins that could affect virulence and pathogenesis. Vet Ital 40, 417-425.
25. ISID ProMED-mail (2007). Bluetongue-Europe (19): BTV-8, Netherlands, suspected. http://www.promedmail.org/?archiveid=20070727.2416
26. Lobato, Z. I., Coupar, B. E., Gray, C. P., Lunt, R. & Andrew, M. E. (1997). Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigens. Vet Immunol Immunopathol 59, 293-309.
27. Maan, N. S., Maan, S., Belaganahalli, M. N., Ostlund, E. N., Johnson, D. J., Nomikou, K. & Mertens, P. P. (2012). Identification and differentiation of the twenty six bluetongue virus serotypes by RT-PCR amplification of the serotype-specific genome segment 2. PLoS ONE 7, e32601.
28. Maan, S., Maan, N. S., Ross-smith, N., Batten, C. A., Shaw, A. E., Anthony, S. J., Samuel, A. R., Darpel, K. E., Veronesi, E. & other authors (2008). Sequence analysis of bluetongue virus serotype 8 from the Netherlands 2006 and comparison to other European strains. Virology 377, 308-318.
29. Maan, S., Maan, N. S., van Rijn, P. A., van Gennip, R. G., Sanders, A., Wright, I. M., Batten, C., Hoffmann, B., Eschbaumer, M. & other authors (2010). Full genome characterisation of bluetongue virus serotype 6 from the Netherlands 2008 and comparison to other field and vaccine strains. PLoS ONE 5, e10323.
30. Maan, S., Maan, N. S., Nomikou, K., Batten, C., Antony, F., Belaganahalli, M. N., Samy, A. M., Reda, A. A., Al-Rashid, S. A. & other authors (2011). Novel bluetongue virus serotype from Kuwait. Emerg Infect Dis 17, 886-889.
31. Maclachlan, N. J., Drew, C. P., Darpel, K. E. & Worwa, G. (2009). The pathology and pathogenesis of bluetongue. J Comp Pathol 141, 1-16.
32. Matsuo, E., Celma, C. C., Boyce, M., Viarouge, C., Sailleau, C., Dubois, E., Bréard, E., Thiéry, R., Zientara, S. & Roy, P. (2011). Generation of replication-defective virus-based vaccines that confer full protection in sheep against virulent bluetongue virus challenge. J Virol 85, 10213-10221.
33. Niedbalski, W. (2011). Bluetongue vaccines in Europe. Pol J Vet Sci 14, 299-304.
34. Noad, R. & Roy, P. (2009a). Bluetongue vaccines. Vaccine 27 (Suppl 4), D86-D89.
35. Noad, R. & Roy, P. (2009b). Bluetongue virus replication and assembly. In Biology of Animal Infections: Bluetongue, pp. 53-76. Edited by P. Mellor, M. Baylis & P. Mertens. Amsterdam: Academic Press.
36. Purse, B. V., Mellor, P. S., Rogers, D. J., Samuel, A. R., Mertens, P. P. C. & Baylis, M. (2005). Climate change and the recent emergence of bluetongue in Europe. Nat Rev Microbiol 3, 171-181.
37. Ratinier, M., Caporale, M., Golder, M., Franzoni, G., Allan, K., Nunes, S. F., Armezzani, A., Bayoumy, A., Rixon, F. & other authors (2011). Identification and characterization of a novel non-structural protein of bluetongue virus. PLoS Pathog 7, e1002477.
38. Roy, P. (2005). Bluetongue virus proteins and particles and their role in virus entry, assembly, and release. Adv Virus Res 64, 69-123.
39. Roy, P., Urakawa, T., Van Dijk, A. A. & Erasmus, B. J. (1990). Recombinant virus vaccine for bluetongue disease in sheep. J Virol 64, 1998-2003.
40. Roy, P., French, T. & Erasmus, B. J. (1992). Protective efficacy of virus-like particles for bluetongue disease. Vaccine 10, 28-32.
41. Roy, P., Boyce, M. & Noad, R. (2009). Prospects for improved bluetongue vaccines. Nat Rev Microbiol 7, 120-128.
42. Sato, M., Tanaka, H., Yamada, T. & Yamamoto, N. (1977). Persistent infection of BHK21/WI-2 cells with rubella virus and characterization of rubella variants. Arch Virol 54, 333-343.
43. Savini, G., Lorusso, A., Paladini, C., Migliaccio, P., Di Gennaro, A., Di Provvido, A., Scacchia, M. & Monaco, F. (2012). Bluetongue serotype 2 and 9 modified live vaccine viruses as causative agents of abortion in livestock: a retrospective analysis in Italy. Transbound Emerg Dis 61, 69-74.
44. Stäuber, N., Martinez-Costas, J., Sutton, G., Monastyrskaya, K. & Roy, P. (1997). Bluetongue virus VP6 protein binds ATP and exhibits an RNA-dependent ATPase function and a helicase activity that catalyze the unwinding of double-stranded RNA substrates. J Virol 71, 7220-7226.
45. Sutton, G., Grimes, J. M., Stuart, D. I. & Roy, P. (2007). Bluetongue virus VP4 is an RNA-capping assembly line. Nat Struct Mol Biol 14, 449-451.
46. Thuenemann, E. C., Meyers, A. E., Verwey, J., Rybicki, E. P. & Lomonossoff, G. P. (2013). A method for rapid production of heteromultimeric protein complexes in plants: assembly of protective bluetongue virus-like particles. Plant Biotechnol J 11, 839-846.
47. Toussaint, J. F., Sailleau, C., Breard, E., Zientara, S. & De Clercq, K. (2007). Bluetongue virus detection by two real-time RT-qPCRs targeting two different genomic segments. J Virol Methods 140, 115-123.
48. Urakawa, T., Ritter, D. G. & Roy, P. (1989). Expression of largest RNA segment and synthesis of VP1 protein of bluetongue virus in insect cells by recombinant baculovirus: association of VP1 protein with RNA polymerase activity. Nucleic Acids Res 17, 7395-7401.
49. van Gennip, R. G. P., van de Water, S. G. P., Maris-Veldhuis, M. & van Rijn, P. A. (2012a). Bluetongue viruses based on modified-live vaccine serotype 6 with exchanged outer shell proteins confer full protection in sheep against virulent BTV8. PLoS ONE 7, e44619.
50. van Gennip, R. G. P., van de Water, S. G. P., Potgieter, C. A., Wright, I. M., Veldman, D. & van Rijn, P. A. (2012b). Rescue of recent virulent and avirulent field strains of bluetongue virus by reverse genetics. PLoS ONE 7, e30540.
51. van Gennip, R. G. P., van de Water, S. G. P. & van Rijn, P. A. (2014). Bluetongue virus nonstructural protein NS3/NS3a is not essential for virus replication. PLoS ONE 9, e85788.
52. van Niekerk, M., Smit, C. C., Fick, W. C., van Staden, V. & Huismans, H. (2001). Membrane association of African horsesickness virus nonstructural protein NS3 determines its cytotoxicity. Virology 279, 499-508.
53. van Rijn, P. A., Geurts, Y., van der Spek, A. N., Veldman, D. & van Gennip, R. G. (2012a). Bluetongue virus serotype 6 in Europe in 2008-emergence and disappearance of an unexpected non-virulent BTV. Vet Microbiol 158, 23-32.
54. van Rijn, P. A., Heutink, R. G., Boonstra, J., Kramps, H. A. & van Gennip, R. G. (2012b). Sustained high-throughput polymerase chain reaction diagnostics during the European epidemic of Bluetongue virus serotype 8. J Vet Diagn Invest 24, 469-478.
55. van Rijn, P. A., van de Water, S. G. & van Gennip, H. G. (2013). Bluetongue virus with mutated genome segment 10 to differentiate infected from vaccinated animals: a genetic DIVA approach. Vaccine 31, 5005-5008.
56. Veronesi, E., Hamblin, C. & Mellor, P. S. (2005). Live attenuated bluetongue vaccine viruses in Dorset Poll sheep, before and after passage in vector midges (Diptera: Ceratopogonidae). Vaccine 23, 5509-5516.
57. Wu, X., Chen, S. Y., Iwata, H., Compans, R. W. & Roy, P. (1992). Multiple glycoproteins synthesized by the smallest RNA segment (S10) of bluetongue virus. J Virol 66, 7104-7112.